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Abstract
Background: Disturbance of the circadian rhythm has 
been associated with disease states, such as metabolic 
disorders, depression and cancer. Quantification of the 
circadian markers such as melatonin and cortisol criti-
cally depend on reliable and reproducible analytical 
methods. Previously, melatonin and cortisol were primar-
ily analyzed separately, mainly using immunoassays.
Methods: Here we describe the validation and application 
of a high-throughput liquid chromatography in combina-
tion with mass spectrometry (LC-MS/MS) method for the 
combined analysis of melatonin and cortisol in plasma 
and saliva. The LC-MS/MS method was validated accord-
ing to international validation guidelines. We used this 
method to analyze total plasma, free plasma (as obtained 
by equilibrium dialysis) and saliva melatonin and cortisol 
in healthy adults.
Results: Validation results for plasma and saliva mela-
tonin and cortisol were well within the international vali-
dation criteria. We observed no difference between saliva 
collected by passive drooling or Salivette. Moreover, we 
noted a significant difference in saliva vs. free plasma 
melatonin. We observed on average 36% (95% CI: 4%–
60%) higher salivary melatonin levels in comparison to 
free plasma melatonin, suggestive of local production of 
melatonin in the salivary glands.
Conclusions: The novel outcome of this study is probably 
due to the high precision of our LC-MS/MS assay. These 
outcomes illustrate the added value of accurate and sensi-
tive mass spectrometry based methods for the quantifica-
tion of neuroendocrine biomarkers.
Keywords: cortisol; dialysis; liquid chromatography in 
combination with mass spectrometry (LC-MS/MS); mela-
tonin; plasma; saliva.
Introduction
There is mounting evidence that disturbance of circadian 
rhythm is involved in the etiology of several disease states 
such as depression, the metabolic syndrome and cancer 
[1, 2]. Typical circadian rhythm markers are melatonin 
and cortisol. Melatonin, a pineal hormone and metabolite 
of the tryptophan-serotonin-pathway is best known for 
its role as a signaling molecule for the length of day and 
night [3, 4]. Cortisol, an adrenal cortex derived glucocor-
ticoid hormone, is at the end-point of the hypothalamic- 
pituitary-adrenal axis, and adapts the body to stress 
conditions by mobilizing energy and inhibiting non-emer-
gency processes, such as sleep, sexual activity and growth 
[5]. The cortisol response is further related to awakening, 
as cortisol peaks after waking up [6].
Quantification of melatonin is still mainly performed 
by immunochemical methods, whereas in recent years 
cortisol determination has shifted towards liquid chroma-
tography in combination with mass spectrometry (LC-MS/
MS). This discrepancy in the methods used is probably 
due to the fact that cortisol is a frequently used diagnostic 
marker in routine patient care (for Cushing’s syndrome) 
[7, 8]. While a few reports have been published on mela-
tonin analysis in saliva or plasma by LC-MS/MS, validation 
was not performed according to internationally accepted 
guidelines [9–12]. When compared to immunoassays 
LC-MS/MS has significant advantages due its better ana-
lytical reproducibility, specificity and standardization. 
Immunoassays tend to lack specificity and show variabil-
ity between vendors [13–16]. Moreover, LC-MS/MS has the 
possibility of measuring multiple analytes in one assay, 
whereas immunoassays are mainly single-analyte assays. 
In circadian rhythm studies measurements of melatonin 
and cortisol are often performed separately, where it would 
be more effective to combine measurements of these ana-
lytes thereby saving sample, time and costs [17–20].
Circadian rhythm studies usually have multiple sam-
pling points on consecutive days and therefore saliva is 
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preferred, as its sampling is noninvasive and more practical 
than blood sampling. Another advantage of saliva is, that 
it reflects the free non-protein bound fraction of plasma, 
which is considered the biologically active fraction [21]. For 
cortisol, the relationship between saliva and plasma free 
cortisol plasma has been extensively studied, and late night 
salivary cortisol is now routinely used as diagnostic test for 
Cushing’s syndrome [22–24]. However, to our knowledge 
there is only one study which describes the relationship 
between total plasma, free plasma, and salivary melatonin, 
which uses an immunoassay [25]. In this study, we inves-
tigated the correlations between total plasma, free plasma 
and salivary cortisol and melatonin levels by a fully vali-
dated LC-MS/MS method and show for the first time a sig-
nificant difference in saliva vs. free plasma melatonin.
Participants and methods
Materials
Water, acetonitrile, methanol, formic acid and ammonium acetate 
were obtained from Biosolve and were ULC/MS grade. Ascorbic acid 
was purchased from Merck. Isopropanol, cortisol, melatonin, cor-
tisone, prednisone and prednisolone were purchased from Sigma-
Aldrich. Deuterated analogs of cortisol (d4) and melatonin (d4) were 
purchased from C/D/N Isotopes.
Sample collection and preparation
Morning blood and saliva samples (8:00 AM) were collected simul-
taneously in 10 non-smoking volunteers. Saliva was collected in two 
ways, either by passive drooling into polypropylene tubes or by corti-
sol Salivettes® (Sarstedt, Nümbrecht, Germany). Participants did not 
eat or drink 30 min before saliva sampling. Salivette rolls were kept in 
the mouth for 1 min and centrifuged at 1000 g for 2 min. One milliliter 
of saliva of passive drooling and Salivette was collected and stored 
at – 20 °C until analysis. Before analysis, saliva was centrifuged for 
5 min at 2000 g. Blood samples were taken via venipuncture, using 
4 mL Vacutainer Tubes (Becton, Dickinson and Company, Franklin 
Lakes, NJ, USA) containing K2-EDTA as anticoagulant. Blood sam-
ples were centrifuged at 2500 g for 15 min and plasma was stored at 
– 20 °C until analysis. Free melatonin and cortisol were determined 
in plasma dialysate obtained by equilibrium dialysis essentially as 
described by Fiers et al. for testosterone [26], with the exception that 
the dialysis membranes used in our study had a 10  kDa pore size 
instead of 25  kDa pore size, as cortisol binding globulin is signifi-
cantly lower in molecular weight than sex hormone binding globu-
lin, 50 and 90 kDa, respectively.
The study was evaluated by the Local Medical Ethics Commit-
tee and waived, because the purpose of this study was to compare 
melatonin and cortisol levels in saliva to the values in plasma and 
the burden for the participants was considered to be very low. All 
participants gave written informed consent.
Analytical procedures
Stock standards for melatonin and cortisol were prepared in metha-
nol at a concentration of 1.0 g/L (melatonin 4.31  mmol/L, cortisol 
2.76 mmol/L). Eight individual calibrators were prepared fresh from 
the stock solution in 0.04% (v/v) ascorbic acid on the day of analysis. 
Calibration curves for saliva were prepared in 0.04% ascorbic acid 
and for plasma in blank plasma. Plasma depleted of melatonin and 
cortisol was prepared by extensive dialyzing plasma against PBS 
using a 10 kDa molecular weight cut-off membrane.
For saliva the calibrator ranges were: melatonin 15–2000 pmol/L, 
and cortisol 0.60–75 nmol/L. For plasma: melatonin 15–2000 pmol/L, 
and cortisol 40–5500  nmol/L. Internal standard working solutions 
for saliva (melatonin 800 pmol/L, cortisol 100 nmol/L) and plasma 
(melatonin 800 pmol/L, cortisol 1000 nmol/L) were prepared on the 
day of analysis in 0.04% (v/v) ascorbic acid. Quality control samples 
were prepared by pooling several saliva or plasma samples and were, 
when necessary, spiked with melatonin and cortisol to give three 
pools (low, medium and high). All samples were stored at − 70 °C 
until use.
For analysis, 250 μL saliva/dialysate, 50 μL internal standard 
solution and 200 μL 0.04% ascorbic acid were added to wells of a 
2.0 mL polypropylene 96-deep well plate (Greiner Bio-One). The plate 
was sealed before being vortex mixed for 10 min. Following vortex-
ing, the plate was transferred to the autosampler and 100 μL was 
injected for analysis.
For plasma analysis, 200 μL of plasma was pipetted into a 
2.0 mL 96-deep well plate (Greiner Bio-One). To this, 50 μL of inter-
nal standard solution was added, and the plate was vortex mixed for 
1 min. Proteins were precipitated by adding 200 μL of 0.3 M zinc sul-
fate in methanol (1 : 5 v/v) and the plate was vortexed again for 1 min. 
Water was added to fill up to 1.0 mL and the plate was sealed and 
centrifuged for 15 min at 2500 × g. Following centrifugation, the plate 
was transferred to the autosampler and 100 μL of the supernatant 
was injected for analysis.
Online solid phase extraction and LC-MS/MS
Online solid phase extraction (SPE) was performed using the 
fully automated Symbiosis™ system (Spark Holland, Emmen, 
The   Netherlands) in eXtraction liquid chromatography (XLC) mode 
as previously described [27]. Oasis HLB (Waters, Milford, USA) car-
tridges were used for extraction. Liquid chromatography (LC) was 
performed on a Phenomenex® Luna Phenyl-Hexyl 2.0 × 100  mm, 
3 μm column (Phenomenex, Torrance, CA, USA) and total run time 
was 6.5 min, including online SPE cleanup. For a complete descrip-
tion of the online SPE and LC method see Supplemental Data. Mela-
tonin and cortisol were analyzed in positive ionization mode on a 
Waters® Xevo™ TQ-MS triple quadrupole mass spectrometer. Mass 
spectrometer settings were optimized by tuning in the selective reac-
tion monitoring mode (SRM). The following settings were applied 
throughout the study: capillary voltage 0.5 kV, desolvation tempera-
ture 600 °C, desolvation gas flow 1000 L/h, cone gas flow 50 L/h and 
collision gas flow 0.15 mL/min. Cone voltage and collision energies 
were optimized for all transitions and are listed in Table 1. Quanti-
fier and qualifier m/z transitions were monitored for melatonin and 
cortisol as well as for their internal standards melatonin-d4 and 
 cortisol-d4.  Quantitation was performed by using the peak-area 
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response ratios of the quantifier transitions for cortisol : cortisol-d4 
and melatonin : melatonin-d4 using the Targetlynx™ software.
Analytical validation
Method validation was performed for saliva and plasma to the same 
extent, unless otherwise stated and based on the guideline for bioan-
alytical method validation from the European Medicines Agency [28].
Linearity of the calibration curves for melatonin and cortisol 
was assessed by analyzing the calibration curves on 12 different 
days. Curves were plotted using least-squares linear regression and 
checked for linearity. To test whether melatonin and cortisol behaved 
the same in water-based calibrators as in saliva-based calibrators, we 
spiked calibration curves in six different saliva samples to compare 
the slope in comparison to water-based calibrators.
Intra-assay variation was determined by analyzing three pooled 
saliva or plasma samples with melatonin and cortisol at low, medium 
and high concentrations in 20 replicates. Inter-assay variation was 
determined by analyzing three pooled saliva or plasma samples on 12 
different days in duplicate over an 8-week period.
Quantification limits for melatonin and cortisol were deter-
mined by serial dilution of a saliva sample (melatonin 20 pmol/L, 
cortisol 0.4 nmol/L,) and plasma sample (melatonin 20 pmol/L, cor-
tisol 130 nmol/L) and analyzing the dilutions on six different days in 
duplicate (for plasma on three different days). LLOQ was set where 
the precision was < 20% and the signal to noise ratio > 10.
Recovery was estimated by spiking melatonin and cortisol at 
three different levels to three different pooled saliva and plasma sam-
ples containing endogenous melatonin and cortisol at three different 
concentration levels. These samples were analyzed on six different 
days (for plasma on three different days). Recovery percentage was 
calculated as follows: [(final concentration – initial concentration)/
added concentration] × 100%. Recovery was considered acceptable 
between 85 and 115%.
Ion suppression was checked by performing a post-column infu-
sion experiment [29]. Solvent, saliva and plasma samples (n = 2) con-
taining a low concentration of melatonin and cortisol were analyzed 
as described above with constant post-column infusion of melatonin 
and cortisol at a flow-rate of 10 μL/min (melatonin and melatonin-d4 
at 800 pmol/L, cortisol, cortisol-d4 at 20 nmol/L). Chromatograms of 
the samples were compared with those of the solvent blank.
Cortisone, prednisone and prednisolone are known compounds 
that can interfere with cortisol analysis. These compounds were 
Table 1: Transitions, cone voltage and collision energy for quantifier 
and qualifier of each compound.




Melatonin-quantifier   233.2 > 174.1   18   14
Melatonin-d4   237.2 > 178.1   18   14
Melatonin-qualifier   233.2 > 159.1   18   27
Melatonin-d4   237.2 > 163.1   18   27
Cortisol-quantifier   363.3 > 121.1   25   23
Cortisol-d4   367.3 > 121.1   25   23
Cortisol-qualifier   363.3 > 327.3   25   16
Cortisol-d4   363.3 > 331.1   25   16
analyzed at a concentration of 100  nmol/L and checked for inter-
ference in the cortisol analysis. For melatonin, n-acetylserotonin, 
6-hydroxymelatonin and 6-sulfatoxymelatonin were analyzed at 
a concentration of 100  nmol/L and checked for interference in the 
melatonin analysis.
Method comparison
Thirty-five anonymized saliva samples, which were analyzed in rou-
tine patient care for cortisol by an existing XLC-MS/MS method, were 
also analyzed by the new method. This routine XLC-MS/MS method 
was developed in our lab based on the method described by Jones 
et al. using C18 cartridges for online SPE and a 3.0 × 150 mm phenyl-
hexyl column [30]. For salivary melatonin, we compared our method 
to a commercial immunoassay from IBL International (Hamburg, 
Germany) using the same saliva samples as mentioned above. Bland-
Altman and Passing-Bablok regression were used for evaluation of 
the results using RStudio [31–33]. Ninety-five percent confidence 
intervals (CI) of slope and intercept were calculated to investigate if 
there was a significant difference (CI of slope should contain 1, CI of 
intercept should contain 0).
Impact of collection device and correlation between  plasma 
total, plasma free and salivary melatonin and cortisol
Saliva was collected by passive drooling (PD) and by Salivette (SAL), 
and plasma from 10 healthy volunteers (six females and four males, 
with respective mean age of 31 and 35 years) to investigate the poten-
tial influence of the collection device on cortisol and/or melatonin. 
Furthermore, we analyzed total and free plasma, and salivary mela-
tonin and cortisol to investigate the correlations in these matrices.
Statistics
Statistical analyses were performed using RStudio [34]. 
 Non-parametric correlations (Spearman’s ρ) were calculated to inves-
tigate the relationship between total plasma free plasma, and saliva 
melatonin and cortisol. A two-sided p < 0.05 was considered statisti-
cally significant. Passing-Bablok regression analysis was performed 
to examine the distribution of melatonin and cortisol between the 
matrices. Ninety-five percent confidence intervals (CI) of slope and 
intercept were calculated to investigate if there was a significant dif-
ference (CI of slope should contain 1, CI of intercept should contain 0).
Results
Assay performance
Total analysis time including automated sample extrac-
tion using the online SPE step was 6.5 min. Representative 
chromatograms obtained for saliva, plasma and plasma 
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dialysate are presented in Figure 1. Chromatographic selec-
tivity was achieved by using a phenyl-hexyl column which 
baseline separates cortisone from cortisol and minimizes 
interference from prednisone (0%) and prednisolone (0.4% 
at 100 nmol/L prednisolone) while maintaining short run 
times. The analytes n-acetylserotonin, 6-hydroxymelatonin 
and 6-sulfatoxymelatonin did not show any interference 
in the melatonin assay. Melatonin and cortisol were not 
baseline separated, but this causes no erroneous results as 
detection is based on different mass over charge ratios of 
the precursor ions and the product ions. Melatonin eluted 
first at 3.26 min, followed by cortisol at 3.37 min.
Method validation
Calibration curves were linear over the calibration range 
for both melatonin and cortisol over n = 12 days with cor-
relation coefficients, R2 > 0.99. Intra-assay CV was below 
9% for cortisol and below 6% for melatonin at all three 
QC levels for saliva and plasma. Inter-assay CV was below 
10% for cortisol and below 9% for melatonin at the three 
QC levels (see Table 2). Complete results for the intra- and 
inter-assay variation of the method for saliva and plasma 
are shown in Table 2. The lower limit of quantification 
(LLOQ) was determined to be 4.0 pmol/L for melatonin, 
and 0.1  nmol/L for cortisol in saliva and 10 pmol/L, 
0.5 nmol/L in plasma for, respectively, melatonin and cor-
tisol. Recoveries for melatonin at the three levels ranged 
from 87% to 98% and from 97% to 111% for cortisol (see 
Table 3). No significant ion suppression was present at the 
retention times where melatonin and cortisol eluted.
Method comparison
In order to verify our method for salivary cortisol, we com-
pared it to the currently used routine LC-MS/MS method 
Figure 1: Representative chromatograms of cortisol and melatonin in plasma, saliva and plasma dialysate from the same individual.
(A) Traces of the plasma sample (cortisol: 429 nmol/L; melatonin 84 pmol/L). (B) Traces of the saliva sample (cortisol: 8.4 nmol/L; 
 melatonin 24 pmol/L) and panel C shows the traces of the plasma dialysate (cortisol: 23 nmol/L; melatonin 24 pmol/L).













Mean   CV, % Mean   CV, % Mean   CV, % Mean   CV, %
Cortisol, nmol/L                
 Low   129   2.3   127   2.6   0.440   8.6   0.477   9.6
 Medium   390   1.0   396   2.7   2.51   2.1   2.58   5.2
 High   848   1.3   864   2.8   11.9   2.1   11.4   4.5
Melatonin, pmol/L               
 Low   20.5   8.9   21.5   9.5   20.8   5.1   20.3   8.9
 Medium   124   3.9   122   4.1   60.4   3.8   59.0   6.8
 High   318   3.5   300   4.2   114   2.8   109   6.0
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Table 3: Mean recovery results for cortisol and melatonin in plasma 
and saliva (ranges between parentheses).
Plasma Saliva
Recovery Recovery 
Mean (range), % Mean (range), %
Cortisol, nmol/L
 Low 92.7 (86–97) 107 (98–116)
 Medium 98.7 (96–103) 100 (95–104)
 High 98.8 (96–101) 100 (95–105)
Melatonin, pmol/L
 Low 96.7 (86–107) 94.3 (87–105)
 Medium 99.3 (92–107) 94.3 (87–111)
 High 102 (91–111) 91.8 (85–112)
Three different samples (native concentrations in parentheses) 
were spiked at three different levels with respectively cortisol and 
melatonin.
for salivary cortisol (Figure 2A and C). The developed 
method compared well to the routine method with a slope 
of 1.02 (95% CI: 1.0–1.05) and an intercept of − 0.05 (95% 
CI: − 0.09 to 0.01). Bland Altman analysis showed a bias of 
0.04 nmol/L between the two methods. For melatonin, we 
compared the developed method to an ELISA (Figure 2B 
and D). The developed method showed some discrepancy 
with the ELISA. In the lower range (< 30 pmol/L), there is 
reasonable agreement, but above > 30 pmol/L the ELISA 
measures considerably lower levels than our LC-MS/
MS assay. Passing-Bablok regression gave a slope of 1.23 
(95% CI: 1.09–1.51) and intercept of − 4.6. (95% CI: − 10 to 
0.2). Bland Altman analysis showed a bias of 7.9 pmol/L 
between the two methods.
Impact of collection device and  correlation 
between total plasma, free plasma and 
salivary melatonin and cortisol
For saliva melatonin and cortisol no significant con-
centration differences were observed between samples 
collected by passive drooling or Salivette in the 
10  samples (see Figure  3A and 4A). Passing-Bablok 
regression gave the following equations, for melatonin: 
Salivette = 1.0 × passive drooling – 0.64; r = 0.98, for cor-
tisol: Salivette = 0.999 × passive drooling – 0.65; r = 0.95. 
As there was no significant difference between saliva col-
lected by passive drooling or Salivette, we used results of 
saliva obtained by passive drooling in calculations pre-
sented below.
Levels of total plasma cortisol correlated moderately 
with free plasma cortisol levels, r = 0.65 (Figure 3B). Free 
plasma cortisol levels correlated well with salivary cor-
tisol levels, r = 0.87, but concentrations in saliva were 
approximately 50% lower compared to free plasma corti-
sol (Saliva = 0.51 × free plasma – 2.1; Figure 3C).
Total plasma melatonin correlated excellently with 
free plasma melatonin, r = 0.98; free plasma = 0.26 × total 
plasma + 1.2, indicating that approximately 75% of mela-
tonin is protein-bound in plasma (Figure 4B). Comparison 
of free plasma melatonin with salivary melatonin showed 
that levels of melatonin in saliva were on average 36% 
higher when compared to levels of free plasma melatonin 
(95% CI = 4–60); passive drooling = 1.36 × free plasma – 1.1 
(Figure 4C).
Discussion
In this study, we describe the characteristics, validation 
and application of a mass spectrometry based method for 
the simultaneous quantification of melatonin and cortisol 
in saliva and plasma. We demonstrated its potential by 
investigating the relationship between total plasma, free 
plasma and salivary melatonin and cortisol, and found 
that melatonin in saliva was on average 36% (95% CI: 
4–60) higher in saliva than free plasma melatonin.
As melatonin and cortisol are frequently analyzed 
in circadian rhythm studies, combined analysis of these 
two neuroendocrine markers is a valuable asset. Quanti-
fication of these markers requires sensitive and accurate 
analytical methods that are routinely applicable. Despite 
the fact that immunoassays have provided a wealth of 
information on biochemical aspects of low molecular 
weight neuroendocrine biomarkers over the past decades, 
these techniques are rapidly being replaced by mass spec-
trometry based methods because of their superior accu-
racy [35]. This is especially true in the field of routinely 
applied biomarkers such as steroids, vitamins, and bio-
genic amines. In the field of chronobiology research still 
mainly relies on immunoassays, despite the fact that 
the limitations of these assays are becoming clear now. 
Melatonin is a (protein bound) low molecular weight bio-
marker that is present at very low concentrations amidst 
numerous potentially interfering structure analogs such 
as serotonin, N-acetylserotonin and kynurenamines. The 
same holds true for cortisol. This makes quantification of 
these markers by immunoassays vulnerable to variation 
in binding protein concentration, matrix and structure 
analog interferences [34, 36, 37].
Recently, two LC-MS/MS methods have been described 
in the literature for the combined analysis of cortisol and 
melatonin in saliva, but none for plasma [10, 11]. The two 
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Salivette = 0.999 × passive drooling −0.65














Free cortisol = 0.021 × total cortisol +11
Spearman's ρ = 0.648
Regression





























Passive drooling = 0.51 × free plasma −2.1 
Spearman's ρ = 0.867 
Regression
A B C
Figure 3: Cortisol: Correlation and Passing-Bablok regression between (A) passive drooling vs. Salivette, (B) total plasma vs. equilibrium 
dialysis, (C) free plasma vs. saliva.
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15
0 5 10 15
Figure 2: Scatter and Bland-Altman plots for the method comparison of saliva cortisol with XLCMS/MS (A, C) and saliva melatonin with com-
mercial immunoassay (B, D). Solid line in the scatterplot (A, B) represents the line of identity.
Passing-Bablok regression analysis gave the following result for cortisol (A) y = 1.02x − 0.05 and for melatonin (B) y = 1.23x − 4.61. Gray area 
represents the 95% confidence interval. Bland-Altman plots are expressed with the method difference as absolute concentration (C, D). 
Dashed lines represent 95% limits of agreement.
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described methods for saliva have certain drawbacks in 
comparison to our method, such as manual sample prep-
aration (liquid-liquid extraction) [10] and a significantly 
higher LLOQ (0.5 nmol/L) for cortisol, which is insufficient 
to quantify late night saliva cortisol levels [11]. Moreover, 
in comparison to the other two published methods for 
cortisol and melatonin in saliva, our method is also suit-
able for plasma analysis. Our method enables efficient 
high throughput analyses of melatonin and cortisol, and 
was recently used in a large longitudinal study in which 
depressed and non-depressed individuals collected saliva 
over 30 days, thrice a day [38, 39].
In several studies in which immunoassays were used, 
it was found that the device for saliva collection can influ-
ence the results for melatonin and cortisol [40–42]. We 
therefore investigated to what extend sample collection 
methods influenced results of our LC-MS/MS assay. We 
found that results for melatonin and cortisol in saliva col-
lected by either passive drooling or Salivette were similar. 
This finding is in line with previous results obtained by 
LC-MS [11]. A possible explanation for this observation 
could be that immunoassays generally are more sensi-
tive to interfering substances as could be coming from 
the Salivette, whereas LC-MS/MS generally is less matrix-
dependent [43]. We compared salivary melatonin results 
from our LC-MS/MS assay to a commercial immunoas-
say designed for use in saliva. The comparison showed 
reasonable agreement, with more scatter in the higher 
calibrator range. A difference in calibration between the 
melatonin immunoassay and our LC-MS/MS assay was 
excluded as explanation for the discrepancy, as calibra-
tors were cross-checked (data not shown). The difference 
in results between IA and MS for salivary melatonin is in 
agreement with a previous publication from Jensen et al. 
which also reports a similar discrepancy between LC-MS/
MS and an immunoassay [44].
In line with previous studies, we found that cortisol 
in saliva correlated well with plasma free cortisol, but 
not with total cortisol in plasma [45, 46]. Levels of cor-
tisol in saliva were approximately half of that of plasma 
free cortisol. One contributing factor to this difference 
is probably the conversion of cortisol to cortisone by 
11β-hydroxysteroid dehydrogenase in the salivary glands 
[47]. Levels of plasma free melatonin were 26% (95% CI: 
22 –30%) of total melatonin in plasma, which corresponds 
well with values reported by Kennaway and Voultsios. 
(mean 23%, range 15–39%) [25]. However, salivary mela-
tonin concentrations were on average 36% (95% CI: 4–60) 
higher than the corresponding plasma free melatonin 
concentrations, which could indicate local production of 
melatonin in the salivary glands. Recently, Shimozuma 
et al. reported the presence of the melatonin-synthesizing 
enzymes arylalkylamine N-acetyltransferase (AANAT) and 
hydroxyindole-O-methyltransferase (HIOMT) in epithelial 
cells of human submandibular glands [48]. Local syn-
thesis of melatonin in salivary glands could explain the 
large variation found in the relation of salivary melatonin 
and plasma concentrations [49, 50]. This is to our knowl-
edge the first study that investigated the relation between 
saliva and plasma dialysate by LC-MS/MS and shows a 
higher concentration of salivary melatonin vs. free plasma 
melatonin obtained by equilibrium dialysis. A limitation 
of this observation is that we only measured samples from 
10 different individuals. To confirm local synthesis of mel-
atonin in the salivary glands, more samples from different 
individuals should be included.
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Spearman's ρ = 0.976 
Regression












Spearman's ρ = 0.976 
















Passive drooling = 1.36 × free plasma −1.1 
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Figure 4: Melatonin: Correlation and Passing-Bablok regression between (A) passive drooling vs. Salivette, (B) total plasma vs. free plasma, 
(C) free plasma vs. saliva.
Gray area represents the 95% confidence interval. Dotted line is the line of identity.
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In summary, we showed that our mass spectrom-
etry based method enables straightforward, reproducible 
and sensitive quantification of cortisol and melatonin in 
human saliva and plasma and illustrates the added value 
of reliable mass spectrometry based methods for the 
quantification of circadian rhythm biomarkers.
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